Research Article
Virulence Factors and Antimicrobial Resistance of Uropathogenic Escherichia coli EQ101 UPEC Isolated from UTI Patient in Quetta, Balochistan, Pakistan
Table 2
The phenotypic resistance profile of EQ101.
| | No. | Antibiotics | Sensitivity | Resistant | Intermediate |
| | 1 | Ampicillin (10 μg) | 35% | 60% | 5% | | 2 | Amoxicillin/clavulanic acid (30 μg) | 70% | 26% | 4% | | 3 | Piperacillin/tazobactam (40 μg) | 80% | 19% | 1% | | 4 | Cefixime (5 μg) | 60% | 38% | 2% | | 5 | Ceftriaxone (30 μg) | 78% | 21% | 1% | | 6 | Ertapenem (10 μg) | 55% | 39% | 6% | | 7 | Amikacin (30 μg) | 51% | 39% | 10% | | 8 | Gentamycin (10 μg) | 55% | 39% | 6% | | 9 | Nalidixic acid (30 μg) | 35% | 60% | 5% | | 10 | Ciprofloxacin (5 μg) | 45% | 48% | 7% | | 11 | Ofloxacin (5 μg) | 34% | 66% | 0% | | 12 | Fosfomycin (50 μg) | 60% | 25% | 15% | | 13 | Nitrofurantoin (300 μg) | 80% | 11% | 9% | | 14 | Sulfamethoxazole-trimethoprim (25 μg) | 37% | 41% | 22% | | 15 | Aztreonam (30 μg) | 58% | 30% | 12% |
|
|
